Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...

Just days after President Trump signed an executive order to broaden access to psychedelic medicines, the United States ...

Last year's $2.5 billion acquisition of Dynavax started to deliver, with a 2.1% rise in vaccine sales to €1.3 billion, driven ...

There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed ...

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, hit by the appreciation of the ...

As more pharmaceutical companies put their hats in the GLP-1 race, with names such as Pfizer, Zealand Pharma, and Amgen due ...

AbbVie's programme of facility announcements in the US has continued with a new 185-acre campus in Durham, North Carolina, ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster ...

Sarclisa (isatuximab) has been approved in the US since 2020, initially for relapsed/refractory multiple myeloma before ...